https://www.rcmishra.com Welcome to Dr Mishra's WebSite Thu, 19 Oct 2023 04:54:27 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.rcmishra.com/anticancer/carbocyclic-nucleosides-in-antiviral-and-anticancer-chemotherapy/ https://www.rcmishra.com/anticancer/carbocyclic-nucleosides-in-antiviral-and-anticancer-chemotherapy/#respond Thu, 19 Oct 2023 04:54:27 +0000 http://rcmishra.com/?p=1519 https://www.rcmishra.com/anticancer/carbocyclic-nucleosides-in-antiviral-and-anticancer-chemotherapy/feed/ 0 https://www.rcmishra.com/anticancer/anticancer-targets-amenable-by-nucleoside-drugs/ https://www.rcmishra.com/anticancer/anticancer-targets-amenable-by-nucleoside-drugs/#respond Thu, 19 Oct 2023 04:54:27 +0000 http://rcmishra.com/?p=1556 https://www.rcmishra.com/anticancer/anticancer-targets-amenable-by-nucleoside-drugs/feed/ 0 https://www.rcmishra.com/anticancer/indian-patent-office-clears-nexavarsorafenib-for-generic-licensing/ https://www.rcmishra.com/anticancer/indian-patent-office-clears-nexavarsorafenib-for-generic-licensing/#respond Thu, 19 Oct 2023 04:54:25 +0000 http://rcmishra.com/?p=1610 https://www.rcmishra.com/anticancer/indian-patent-office-clears-nexavarsorafenib-for-generic-licensing/feed/ 0 https://www.rcmishra.com/anticancer/bosutinib-bosulif-approved-for-leukemia-by-pfizer/ https://www.rcmishra.com/anticancer/bosutinib-bosulif-approved-for-leukemia-by-pfizer/#respond Thu, 19 Oct 2023 04:54:21 +0000 http://rcmishra.com/?p=1827 https://www.rcmishra.com/anticancer/bosutinib-bosulif-approved-for-leukemia-by-pfizer/feed/ 0 https://www.rcmishra.com/anticancer/centrosome-declustering-an-anticancer-strategy/ https://www.rcmishra.com/anticancer/centrosome-declustering-an-anticancer-strategy/#respond Thu, 19 Oct 2023 04:54:21 +0000 http://rcmishra.com/?p=1840 https://www.rcmishra.com/anticancer/centrosome-declustering-an-anticancer-strategy/feed/ 0 https://www.rcmishra.com/anticancer/design-development-of-unnatural-nucleosides-as-antiviral-anti-cancer-agents/ https://www.rcmishra.com/anticancer/design-development-of-unnatural-nucleosides-as-antiviral-anti-cancer-agents/#comments Thu, 19 Oct 2023 04:54:20 +0000 http://www.rcmishra.com/?p=1866 Read more]]> https://www.rcmishra.com/anticancer/design-development-of-unnatural-nucleosides-as-antiviral-anti-cancer-agents/feed/ 1 https://www.rcmishra.com/anticancer/gemcitabine-prodrug-as-new-anticancer-clinical-candidate/ https://www.rcmishra.com/anticancer/gemcitabine-prodrug-as-new-anticancer-clinical-candidate/#respond Thu, 19 Oct 2023 04:54:18 +0000 http://www.rcmishra.com/?p=2041 Read more]]> https://www.rcmishra.com/anticancer/gemcitabine-prodrug-as-new-anticancer-clinical-candidate/feed/ 0